| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.31 | 6e-21 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.22 | 2e-11 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.34 | 1e-10 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.2 | 2e-09 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.21 | 2e-09 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.28 | 1e-07 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.3 | 4e-07 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.25 | 4e-06 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.25 | 2e-05 |